Factor Replacement Therapy is a medical treatment primarily used for individuals with bleeding disorders, such as hemophilia. This therapy involves administering specific clotting factors that are either derived from human plasma or produced through recombinant DNA technology. The goal is to replace the missing or deficient factors in the blood, helping to prevent or control bleeding episodes. Patients typically receive these treatments through intravenous infusions, which can be done in a clinical setting or at home. Regular use of Factor Replacement Therapy can significantly improve the quality of life for those affected by bleeding disorders, allowing them to engage in daily activities with reduced risk of bleeding.